Report the issue to the FDA
A Note for Mothers with Obesity If you have obesity, your situation is more complicated (and potentially more nuanced) than the general guidance above suggests
333 participants entered into the extension trial and were followed for an additional 52 weeks off treatment
Single-dose prefilled syringes: Injection: clear, colorless solution of 0.5 mg/mL, 1 mg/mL, 2 mg/mL of semaglutide available in the following packaging configurations: Recommended Storage Conditions for OZEMPIC Single-patient-use pens (with multiple weekly doses): Prior to first use, the OZEMPIC pen should be stored in a refrigerator between 2C to 8C (36F to 46F)
Conditions that prevent use include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, a history of severe pancreatitis, pregnancy, and active gallbladder disease